Standard Chemical & Pharmaceutical Co. Ltd. - Taiwan
12 Months ended Dec. 31:
Figures in New Taiwan dollars.
2025 2024
Revenue NT$7,023,025,000 NT$6,789,223,000
Pretax Profit NT$1,513,876,000 NT$1,627,359,000
Net Profit NT$927,659,000 NT$880,501,000
Earnings Per Share
Basic 5.19 4.93
Diluted 5.18 4.92
Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.
(END) Dow Jones Newswires
February 25, 2026 01:23 ET (06:23 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.